• ID 342822543 © Rafael Fores | Dreamstime.com
    dreamstime_xxl_342822543_1
    LABline
    May 27, 2025
    Foresight Diagnostics, Inc. announced the presentation of independent validation data demonstrating the prognostic performance of its Foresight CLARITY MRD assay in patients with...
    By Keopaserth on Adobe Stock
    adobestock_1168120491
    MLO April QuickChat
    Courtesy of Bruker
    begenius
    Courtesy of Thermo Fisher Scientific
    thermo_fisher_scientific_one_lambda_hybritype_hla_
    ID 361325299 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_361325299
    Courtesy of Revvity
    product_image
    LABline
    March 5, 2025
    Company expands infectious disease diagnostics portfolio.
    ID 323032177 © Leo Rohmann | Dreamstime.com
    dreamstime_xxl_323032177
    ID 360501051 © Prostockstudio | Dreamstime.com
    dreamstime_xxl_360501051
    LABline
    Feb. 19, 2025
    The test was first granted Emergency Use Authorization (EUA) status in May 2020.
    ID 339643448 © Yuri Arcurs | Dreamstime.com
    dreamstime_xxl_339643448
    LABline
    Jan. 30, 2025
    The Roche Diagnostics Tina-quant Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein (a) in a person’s bloodstream (serum and plasma), and will be broadly...
    ID 239686664 © Chernetskaya | Dreamstime.com
    dreamstime_xxl_239686664
    LABline
    Jan. 24, 2025
    FDA CLIA-waived tests broaden access to accurate, easy-to-use diagnostics for all patients in decentralized settings like urgent care centers, retail clinics, and community health...
    MLO Staff
    Dec. 23, 2024
    Extend the power of HPV testing BD Onclarity HPV Assay offers extended genotyping to identify high-risk HPV types beyond 16, 18, and 45 and is approved for self-collection in ...
    curveimage
    Nov. 13, 2024
    As diabetes management evolves, the use of advanced testing technologies like ion-exchange high-performance liquid chromatography (HPLC) for A1C (or HbA1c) testing has become ...
    Courtesy of Caris Life Sciences
    PIQRAY® is a registered trademark of Novartis AG. VECTIBIX® is a registered trademark of Immunex Corporation. BRAFTOVI® is a registered trademark of Array BioPharma Inc. in the United States and various other countries. ERBITUX® is a registered trademark of ImClone LLC, a wholly owned subsidiary of Eli Lilly and Company. MEKINIST® is a registered trademark of Novartis AG Corporation Switzerland. KEYTRUDA® is a registered trademark of Merck. LENVIMA® (lenvatinib) is a registered trademark used by Eisai Inc. under license from Eisai R&D Management Co., Ltd.
    LABline
    Nov. 8, 2024
    MI Cancer Seek is the first and only simultaneous whole exome and whole transcriptome-based assay with CDx indications for adults and pediatric patients.
    Courtesy of Yourgene Health
    yourgene_cystic_fibrosis_base_assay_ivdr
    LABline
    Oct. 18, 2024
    Offers clinicians and patients additional confidence in quality and accuracy of test for cystic fibrosis diagnosis.
    sekisui_header
    Sept. 20, 2024
    Accessible and Accurate Testing Solutions from Home to Lab by Sekisui Diagnostics.Sponsored by:

    Assays

    ID 314050690 © Svetlana Diacenco | Dreamstime.com
    dreamstime_xxl_314050690
    hero_0924
    Courtesy of QuidelOrtho
    7600_front_transparent
    ADLM 2024: DIASORIN
    Courtesy of Bio-Rad
    spiaplusproductimage2
    Courtesy of Thermo Fisher
    Photo 323621432 © Aumporn Charicha | Dreamstime.com